BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cucchiara S, Staiano A, Boccieri A, De Stefano M, Capozzi C, Manzi G, Camerlingo F, Paone FM. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut 1990;31:21-5. [PMID: 2180792 DOI: 10.1136/gut.31.1.21] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Morita T, Furuta K, Adachi K, Ohara S, Tanimura T, Koshino K, Uemura T, Naora K, Kinoshita Y. Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux. J Neurogastroenterol Motil 2012;18:181-6. [PMID: 22523727 DOI: 10.5056/jnm.2012.18.2.181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
2 Greally P, Hampton FJ, MacFadyen UM, Simpson H. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux. Arch Dis Child. 1992;67:618-621. [PMID: 1599300 DOI: 10.1136/adc.67.5.618] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
3 Ewer AK, James ME, Tobin JM. Prone and left lateral positioning reduce gastro-oesophageal reflux in preterm infants. Arch Dis Child Fetal Neonatal Ed 1999;81:F201-5. [PMID: 10525024 DOI: 10.1136/fn.81.3.f201] [Cited by in Crossref: 57] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
4 Vandenplas Y, Belli D, Benhamou PH, Cadranel S, Cezard JP, Cucchiara S, Dupont C, Faure C, Gottrand F, Hassall E, Heymans HS, Kneepkens CM, Sandhu BK. Current concepts and issues in the management of regurgitation of infants: a reappraisal. Management guidelines from a working party. Acta Paediatr 1996;85:531-4. [PMID: 8827092 DOI: 10.1111/j.1651-2227.1996.tb14079.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
5 Scott RB, Ferreira C, Smith L, Jones AB, Machida H, Lohoues MJ, Roy CC. Cisapride in pediatric gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 1997;25:499-506. [PMID: 9360203 DOI: 10.1097/00005176-199711000-00003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
6 Staiano A, Troncone R, Simeone D, Mayer M, Finelli E, Cella A, Auricchio S. Differentiation of cows' milk intolerance and gastro-oesophageal reflux. Arch Dis Child. 1995;73:439-442. [PMID: 8554363 DOI: 10.1136/adc.73.5.439] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
7 Shulman RJ, Boyle JT, Colletti RB, Friedman RA, Heyman MB, Kearns G, Kirschner BS, Levy J, Mitchell AA, Van Hare G. The use of cisapride in children. The North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1999;28:529-533. [PMID: 10328132 DOI: 10.1097/00005176-199905000-00018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
8 Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2010;:CD002300. [PMID: 20393933 DOI: 10.1002/14651858.CD002300.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Vandenplas Y, Hachimi-Idrissi S, Casteels A, Mahler T, Loeb H. A clinical trial with an "anti-regurgitation" formula. Eur J Pediatr 1994;153:419-23. [PMID: 8088297 DOI: 10.1007/BF01983405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.0] [Reference Citation Analysis]
10 James LP. Pharmacology for the gastrointestinal tract. Clinics in Perinatology 2002;29:115-33. [DOI: 10.1016/s0095-5108(03)00067-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Faure C, Leluyer B, Aujard Y, de Bethmann O, Bedu A, Briand E, Boige N, Brusquet Y, Benhamou P, Cézard J, Chapoy P, Dabadie A, Dehan M, Dupont C, Gabilan J, Gottrand F, Mallet E, Maurage C, Mouterde O, Olives J, Sarles J, Schmitz J, Turck D, Vidailhet M, Navarro J. Position de sommeil, prévention de la mort subite du nourrisson et reflux gastroœsophagien. Archives de Pédiatrie 1996;3:598-601. [DOI: 10.1016/0929-693x(96)83234-9] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
12 Augood C, MacLennan S, Gilbert R, Logan S. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2003;:CD002300. [PMID: 14583950 DOI: 10.1002/14651858.CD002300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, Gerson WT, Werlin SL. Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2001;32:S1-S31. [DOI: 10.1097/00005176-200100002-00001] [Cited by in Crossref: 442] [Cited by in F6Publishing: 342] [Article Influence: 21.0] [Reference Citation Analysis]
14 Staiano A, Cucchiara S, Andreotti MR, Minella R, Manzi G. Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci 1991;36:733-6. [PMID: 2032513 DOI: 10.1007/BF01311229] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Novak DA. Gastroesophageal Reflux in the Preterm Infant. Clinics in Perinatology 1996;23:305-20. [DOI: 10.1016/s0095-5108(18)30244-6] [Cited by in Crossref: 13] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kawahara H, Tazuke Y, Soh H, Yoneda A, Fukuzawa M. Physiological analysis of the effects of rikkunshito on acid and non-acid gastroesophageal reflux using pH-multichannel intraluminal impedance monitoring. Pediatr Surg Int 2014;30:927-31. [DOI: 10.1007/s00383-014-3565-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mfoafo KA, Omidian M, Bertol CD, Omidi Y, Omidian H. Neonatal and pediatric oral drug delivery: Hopes and hurdles. Int J Pharm 2021;597:120296. [PMID: 33524524 DOI: 10.1016/j.ijpharm.2021.120296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sikavi DR, Cai JX, Carroll TL, Chan WW. Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms. J Gastroenterol Hepatol 2021;36:2076-82. [PMID: 33373479 DOI: 10.1111/jgh.15391] [Reference Citation Analysis]
19 Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, Fukuzawa M. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int 2007;23:1001-5. [PMID: 17668223 DOI: 10.1007/s00383-007-1986-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
20 Cohen RC, O'Loughlin EV, Davidson GP, Moore DJ, Lawrence DM. Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial. J Pediatr. 1999;134:287-292. [PMID: 10064663 DOI: 10.1016/S0022-3476(99)70451-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
21 Enriquez A, Bolisetty S, Patole S, Garvey PA, Campbell PJ. Randomised controlled trial of cisapride in feed intolerance in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;79:F110-3. [PMID: 9828736 DOI: 10.1136/fn.79.2.f110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kawahara H, Mitani Y, Nomura M, Nose K, Yoneda A, Hasegawa T, Kubota A, Fukuzawa M. Impact of rikkunshito, an herbal medicine, on delayed gastric emptying in profoundly handicapped patients. Pediatr Surg Int 2009;25:987-90. [DOI: 10.1007/s00383-009-2453-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
23 Lander A, Desai A. The risks and benefits of cisapride in premature neonates, infants, and children. Arch Dis Child 1998;79:469-70. [PMID: 10210987 DOI: 10.1136/adc.79.6.469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
24 Cucchiara S. Cisapride therapy for gastrointestinal disease. J Pediatr Gastroenterol Nutr 1996;22:259-69. [PMID: 8708879 DOI: 10.1097/00005176-199604000-00007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
25 Cho YK, Choi MG, Park EY, Lim CH, Kim JS, Park JM, Lee IS, Kim SW, Choi KY. Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry. Dig Dis Sci. 2013;58:1035-1041. [PMID: 23053900 DOI: 10.1007/s10620-012-2430-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
26 Jenkins HR, Verrier-Jones K. Vomiting and chronic renal failure. Pediatr Nephrol 1991;5:436. [PMID: 1911118 DOI: 10.1007/BF01453675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Malfroot A, Dab I. New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. Arch Dis Child. 1991;66:1339-1345. [PMID: 1755649 DOI: 10.1136/adc.66.11.1339] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
28 Autret E, Jonville-bera A, Champel V. La toxicité cardiaque du cisapride (Prépulsid®) mérite d'être prise en compte dans sa prescription, en particulier chez le prématuré. Archives de Pédiatrie 1997;4:507-8. [DOI: 10.1016/s0929-693x(97)87567-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
29 Gold BD, Freston JW. Gastroesophageal Reflux in Children: Pathogenesis, Prevalence, Diagnosis, and Role of Proton Pump Inhibitors in Treatment. Pediatric Drugs 2002;4:673-85. [DOI: 10.2165/00128072-200204100-00004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
30 Levy J, Hayes C, Kern J, Harris J, Flores A, Hyams J, Murray R, Tolia V. Does cisapride influence cardiac rhythm? Results of a United States multicenter, double-blind, placebo-controlled pediatric study. J Pediatr Gastroenterol Nutr 2001;32:458-63. [PMID: 11396814 DOI: 10.1097/00005176-200104000-00013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
31 Kawai M, Kawahara H, Hirayama S, Yoshimura N, Ida S. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2004;38:317-323. [PMID: 15076634 DOI: 10.1097/00005176-200403000-00017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
32 Gershon A. Varicella: to vaccinate or not to vaccinate? Arch Dis Child 1998;79:470-1. [PMID: 10210988 DOI: 10.1136/adc.79.6.470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
33 Preechagoon Y, Charles B, Piotrovskij V, Donovan T, Van Peer A. Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease. Br J Clin Pharmacol 1999;48:688-93. [PMID: 10594470 DOI: 10.1046/j.1365-2125.1999.00068.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
34 Booth IW. Silent gastro-oesophageal reflux: how much do we miss? Arch Dis Child 1992;67:1325-7. [PMID: 1471881 DOI: 10.1136/adc.67.11.1325] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
35 Shulman RJ. Cisapride doesn't work? Don't go breakin' my heart! J Pediatr 1999;134:262-4. [PMID: 10064658 DOI: 10.1016/s0022-3476(99)70446-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Vandenplas Y, Hegar B. Diagnosis and treatment of gastro‐oesophageal reflux disease in infants and children. Journal of Gastroenterology and Hepatology 2001;15:593-603. [DOI: 10.1046/j.1440-1746.2000.02169.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
37 Faure C, Besnard M, Cézard J. Traitement du reflux gastroœsophagien. Archives de Pédiatrie 1995;2:263-6. [DOI: 10.1016/0929-693x(96)81139-0] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
38 Yvan V. Diagnosis and treatment of gastroesophageal reflux disease in infants and children. World J Gastroenterol 1999; 5(5): 375-382 [PMID: 11819472 DOI: 10.3748/wjg.v5.i5.375] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
39 Kulik W, van Weissenbruch MM, Menelik N, Cranendonk A, Kneepkens C, Lafeber HN. Improved use of the [13C]octanoic acid breath test as intra-individual parameter to study the effect of a prokinetic drug on gastric emptying in preterm infants with oral feeding intolerance. Journal of Chromatography B: Biomedical Sciences and Applications 2001;750:147-53. [DOI: 10.1016/s0378-4347(00)00441-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Sullivan PB. Gastrointestinal problems in the neurologically impaired child. Baillière's Clinical Gastroenterology 1997;11:529-46. [DOI: 10.1016/s0950-3528(97)90030-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
41 Chetcuti P, Phelan PD. Respiratory morbidity after repair of oesophageal atresia and tracheo-oesophageal fistula. Arch Dis Child. 1993;68:167-170. [PMID: 8481036 DOI: 10.1136/adc.68.2.167] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 2.7] [Reference Citation Analysis]
42 Barone JA, Jessen LM, Colaizzi JL, Bierman RH. Cisapride: A Gastrointestinal Prokinetic Drug. Ann Pharmacother 1994;28:488-500. [DOI: 10.1177/106002809402800413] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
43 Grande L, Lacima G, Ros E, García-Valdecasas JC, Fuster J, Visa J, Pera C. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study. Dig Dis Sci 1992;37:583-8. [PMID: 1551349 DOI: 10.1007/BF01307583] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
44 Vandenplas Y; ESPGHAN Cisapride Panel. European Society for Pediatric Gastroenterology, Hepatology and Nutrition. Current pediatric indications for cisapride. J Pediatr Gastroenterol Nutr 2000;31:480-9. [PMID: 11144431 DOI: 10.1097/00005176-200011000-00006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
45 Staiano A, Cucchiara S, Del Giudice E, Andreotti MR, Minella R. Disorders of oesophageal motility in children with psychomotor retardation and gastro-oesophageal reflux. Eur J Pediatr 1991;150:638-41. [DOI: 10.1007/bf02072624] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
46 Gorenstein A, Levine A, Boaz M, Mandelberg A, Serour F. Severity of acid gastroesophageal reflux assessed by pH metry: is it associated with respiratory disease? Pediatr Pulmonol 2003;36:330-4. [PMID: 12950047 DOI: 10.1002/ppul.10361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
47 Yu VY. Enteral feeding in the preterm infant. Early Human Development 1999;56:89-115. [DOI: 10.1016/s0378-3782(99)00047-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Baujat G, Faure C, Zaouche A, Viarme F, Couly G, Abadie V. Oroesophageal motor disorders in Pierre Robin syndrome. J Pediatr Gastroenterol Nutr 2001;32:297-302. [PMID: 11345179 DOI: 10.1097/00005176-200103000-00012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
49 Olafsdottir E. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride. Scand J Gastroenterol Suppl 1995;211:32-4. [PMID: 8545628 DOI: 10.3109/00365529509090291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
50 Tack J, Coremans G, Janssens J. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. Drug Saf 1995;12:384-92. [PMID: 8527013 DOI: 10.2165/00002018-199512060-00004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
51 Quigley EM. Cisapride: what can we learn from the rise and fall of a prokinetic? J Dig Dis. 2011;12:147-156. [PMID: 21615867 DOI: 10.1111/j.1751-2980.2011.00491.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
52 Glassman M, George D, Grill B. GASTROESOPHAGEAL REFLUX IN CHILDREN. Gastroenterology Clinics of North America 1995;24:71-98. [DOI: 10.1016/s0889-8553(21)00249-1] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
53 Van Herwaarden MA, Samsom M, Van Nispen CH, Verlinden M, Smout AJ. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Aliment Pharmacol Ther. 2000;14:453-462. [PMID: 10759625 DOI: 10.1046/j.1365-2036.2000.00712.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
54 Gunasekaran T, Dubrow I. Cisapride-induced long QT interval: What is therole of ranitidine? The Journal of Pediatrics 1997;130:679-80. [DOI: 10.1016/s0022-3476(97)70264-6] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
55 Milla PJ. Reflux vomiting. Arch Dis Child 1990;65:996-9. [PMID: 2221978 DOI: 10.1136/adc.65.9.996] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
56 Vandenplas Y, Benatar A, Cools F, Arana A, Hegar B, Hauser B. Efficacy and Tolerability of Cisapride in Children: . Paediatric Drugs 2001;3:559-73. [DOI: 10.2165/00128072-200103080-00001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
57 Patel R, Launspach J, Soffer E. Effects of cisapride on salivary production in normal subjects. Digest Dis Sci 1996;41:480-4. [DOI: 10.1007/bf02282322] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Hyman PE. Gastroesophageal reflux: One reason why baby won't eat. The Journal of Pediatrics 1994;125:S103-9. [DOI: 10.1016/s0022-3476(05)82933-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
59 Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, Müller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35:745-767. [PMID: 22356640 DOI: 10.1111/j.1365-2036.2012.05011.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 174] [Article Influence: 18.3] [Reference Citation Analysis]